Jianbin Li

4PUBLICATIONS
35CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMajor global burdens of disease
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|May 20, 2026
Pertuzumab Vs. Pyrotinib in Combination With Trastuzumab and Taxanes for First-Line Treatment of HER2+ MBC: A Multicenter Real-World Study.

|Sep 16, 2025
Real-World Treatment Patterns and Survival Outcomes in Metastatic Triple Negative Breast Cancer: Immunotherapy- Versus Anti-Angiogenic Therapy-Combined-With-Chemotherapy.

Yingzhe Wang, Song Wu, Jianbin Li

|Dec 07, 2023
Safety of COVID-19 Vaccination in Patients With Breast Cancer: Cross-Sectional Study in China.

Shaohua Zhang, Jianbin Li, Ruonan Xu

|Jun 09, 2023
HPIP is an essential scaffolding protein running through the EGFR-RAS-ERK pathway and drives tumorigenesis.

Qiwei Jiang, Deyu Zhang, Juan Liu

Pageof 1

Frequent Collaborators

1 joint publications

Qiwei Jiang

1 joint publications

Deyu Zhang

1 joint publications

Juan Liu

1 joint publications

Chaoyang Liang